Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Ischemic mitral regurgitation: current trends and treatment

Elmistekawy, Elsayed; Mesana, Thierry; Chan, Vincent

doi: 10.1097/HCO.0b013e3283654725
CORONARY ARTERY SURGERY: Edited by Thierry Mesana
Buy

Purpose of review Ischemic mitral regurgitation (MR) is a common finding in patients with coronary artery disease. In this review, we summarize the current literature describing the treatment of ischemic mitral regurgitation.

Recent findings Recent publications have focused on describing outcomes following the treatment of ischemic mitral regurgitation based on the specific mechanism of regurgitation. New therapies such as remodeling rings and percutaneous approaches, along with insights into mitral valve replacement, have advanced the treatment of ischemic mitral regurgitation.

Summary Mitral valve surgery and concomitant coronary artery bypass grafting represent the most effective strategy for the treatment of severe symptomatic ischemic mitral regurgitation. Overall, the survival of patients with ischemic mitral regurgitation is poor. Advances in mitral valve repair may improve long-term durability of surgery, whereas evolving percutaneous therapies may be a treatment option for patients with functional mitral regurgitation who are not surgical candidates.

Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Correspondence to Vincent Chan, MD, MPH, FRCSC, Assistant Professor, Department of Surgery, Department of Epidemiology and Community Medicine, University of Ottawa Heart Institute, Ottawa, ON K1Y4W7, Canada. Tel: +1 613 761 4253; fax: +1 613 761 5107; e-mail: vchan@ottawaheart.ca

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins